Illumina, Inc. today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than ...
UD developmental biologist studies genetics of jaw joint disorder with NIH funding ...